Possibly the most undervalued stock on the TSX!
- 19M mkt cap / 11M float
- 28.4M cash eq.
- 17.1M Q3 revenue / 7M adjusted EBITDA
- Options at $3.27
- Warrants at $3.53
- Enterprise value (as of Sep 30, 2021): 103.8M!!
- Canadian Commercial business is focused on Pain, Neurology, Allergy, And Dermatology therapeutics.
- 17 Global Distribution Partners across 31 Countries.
- Over 100 global patents and patent applications
- 20+ products, 7 proprietary products, ~ 100 employees
- 28.4M cash eq.
- 17.1M Q3 revenue / 7M adjusted EBITDA
- Options at $3.27
- Warrants at $3.53
- Enterprise value (as of Sep 30, 2021): 103.8M!!
- Canadian Commercial business is focused on Pain, Neurology, Allergy, And Dermatology therapeutics.
- 17 Global Distribution Partners across 31 Countries.
- Over 100 global patents and patent applications
- 20+ products, 7 proprietary products, ~ 100 employees
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。